Aurobindo Receives Final FDA Nod For Venlafaxine Hydrochloride Tablets

Aurobindo Pharma said that Venlafaxine Hydrochloride tablets are the generic equivalent of Wythe Pharmaceutical’s Effexor tablets.

Effexor XR (venlafaxine hydrochloride) extended-release capsules are prescription antidepressant and indicated for the treatment of depression, generalised anxiety disorder (GAD), social anxiety disorder (SAD) and panic disorder (PD) with or without agoraphobia.

Venlafaxine Hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) and falls under the therapeutic category of CNS (Central Nervous System). The product is expected to be launched shortly.

Venlafaxine (Effexor, Efexor, Alventa, Argofan, Trevilor) is an arylalkanolamine serotonin-norepinephrine reuptake inhibitor (SNRI). First introduced by Wyeth in 1993.

Hyderabad, India-based Aurobindo manufactures generic pharmaceuticals and active pharmaceutical ingredients. It has a total of 114 ANDA approvals (85 Final approvals and 29 Tentative approvals) from FDA.